{"title":"抗血小板药物:综述","authors":"Asma Haffouz, A. Gargouri, Basma Hadjkacem","doi":"10.4103/jasmr.jasmr_35_22","DOIUrl":null,"url":null,"abstract":"Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of cardiovascular diseases. They may target the three principal phases leading to thrombogenesis, including platelet adhesion, activation, and aggregation. This review presents an overview of the currently available antiplatelet agents, with a particular focus on their targets, pharmacological properties, and limitation of use.","PeriodicalId":276353,"journal":{"name":"Journal of The Arab Society for Medical Research","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiplatelet agents: an overview\",\"authors\":\"Asma Haffouz, A. Gargouri, Basma Hadjkacem\",\"doi\":\"10.4103/jasmr.jasmr_35_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of cardiovascular diseases. They may target the three principal phases leading to thrombogenesis, including platelet adhesion, activation, and aggregation. This review presents an overview of the currently available antiplatelet agents, with a particular focus on their targets, pharmacological properties, and limitation of use.\",\"PeriodicalId\":276353,\"journal\":{\"name\":\"Journal of The Arab Society for Medical Research\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of The Arab Society for Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jasmr.jasmr_35_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The Arab Society for Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jasmr.jasmr_35_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of cardiovascular diseases. They may target the three principal phases leading to thrombogenesis, including platelet adhesion, activation, and aggregation. This review presents an overview of the currently available antiplatelet agents, with a particular focus on their targets, pharmacological properties, and limitation of use.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
